Zobrazeno 1 - 10 of 43 pro vyhledávání: '"Sandra, Gallach"'
2
Akademický článek
Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer
Autor: Susana Torres-Martínez, Silvia Calabuig-Fariñas, Sandra Gallach, Marais Mosqueda, Ester Munera-Maravilla, Rafael Sirera, Lara Navarro, Ana Blasco, Carlos Camps, Eloisa Jantus-Lewintre
Publikováno v: International Journal of Molecular Sciences, Vol 24, Iss 24, p 17587 (2023)
Immunotherapy has been proven a viable treatment option for non-small cell lung cancer (NSCLC) treatment in patients. However, some patients still do not benefit. Finding new predictive biomarkers for immunocheckpoint inhibitor (ICI) response will im
Externí odkaz: https://doaj.org/article/4dff53ea28344440a8c674c8c3cb60c4
Zobrazit plný text záznamu
4
A Sonic Hedgehog Pathway Score to Predict the Outcome of Resected Non-Small Cell Lung Cancer Patients
Autor: Alejandro Herreros-Pomares, Paula Doria, Sandra Gallach, Marina Meri-Abad, Ricardo Guijarro, Silvia Calabuig-Fariñas, Carlos Camps, Eloísa Jantus-Lewintre
Publikováno v: ANNALS OF SURGICAL ONCOLOGY
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Universitat Rovira i virgili (URV)
Background Mutations and deregulations in components of the Hedgehog (Hh) pathway have been associated with cancer onset and tumor growth in different malignancies, but their role in non-small cell lung cancer (NSCLC) remains unclear. This study aims
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::224b59c2f749b4893f93d84e2cf0adac
https://fundanet.cipf.es/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4009
Zobrazit plný text záznamu
5
Clinical and technical insights of tumour mutational burden in non-small cell lung cancer
Autor: Marina Meri-Abad, Andrea Moreno-Manuel, Sandra Gallach García, Silvia Calabuig-Fariñas, Rafael Sirera Pérez, Carlos Camps Herrero, Eloisa Jantus-Lewintre
Publikováno v: Critical Reviews in Oncology/Hematology. 182:103891
Despite the durable responses provided by the introduction of checkpoint inhibitors in advanced Non-Small Cell Lung Cancer (NSCLC) without actionable targets in a subset of patients, a large proportion of them will progress after immunotherapy. Progr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9d7bb39761cba7ff990bd5fd04baf58
https://doi.org/10.1016/j.critrevonc.2022.103891
Zobrazit plný text záznamu
6
Oral microbiome in Proliferative Verrucous Leukoplakia exhibits loss of diversity and enrichment of pathogens
Autor: Jose V. Bagan, Eloisa Jantus-Lewintre, Judith Murillo, Beatriz Soriano, Alejandro Herreros-Pomares, Leticia Bagan, Carlos Llorens, F. Zhang, Sandra Gallach
Publikováno v: Oral oncology. 120
Objectives Oral microbiome plays an important role in oral diseases. Among them, proliferative verrucous leucoplakia (PVL) is an uncommon form of progressive multifocal leukoplakia with a worryingly rate of malignant transformation. Here, we aimed to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16242a0830b74698b75c4657285b2b09
https://pubmed.ncbi.nlm.nih.gov/34225130
Zobrazit plný text záznamu
7
Characterization of Circulating T Cell Receptor Repertoire Provides Information about Clinical Outcome after PD-1 Blockade in Advanced Non-Small Cell Lung Cancer Patients
Autor: F. Zhang, Ana Blasco, Andrea Moreno-Manuel, Ning Dong, Eloisa Jantus-Lewintre, Silvia Calabuig-Fariñas, Sandra Gallach, Carlos Camps, Ricardo Guijarro, Francisco Aparisi, Marina Meri-Abad, Rafael Sirera
Publikováno v: Cancers
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Universitat Rovira i virgili (URV)
Volume 13
Issue 12
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
r-FISABIO. Repositorio Institucional de Producción Científica
Cancers, Vol 13, Iss 2950, p 2950 (2021)
Despite the success of immunotherapies in lung cancer, development of new biomarkers for patient selection is urgently needed. This study aims to explore minimally invasive approaches to characterize circulating T cell receptor beta chain (TCR-β) re
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a73d558cd73e6b62af6b8ca112a84b3
https://fundanet.cipf.es/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3791
Zobrazit plný text záznamu
10
ANÁLISIS DE MICROARNS EN CÁNCER DE PULMÓN NO MICROCÍTICO
Autor: Sandra Gallach García
Publikováno v: RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
instname
Lung cancer is the leading cause of death cancer-related worldwide, and is the third most common cancer type. The non-small cell lung cancer (NSCLC) comprises almost 85% of all lung cancers and the 5-year survival rate remains poor. The microRNAs (mi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30fb823b1043cd7f5b8e1e20fffe2322
http://hdl.handle.net/10251/90428
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje